The 20 Best Friedreich Ataxia Doctors Near Me in Ann Arbor, MI

Dr. Schmidt attended medical school at Michigan State University, and completed her residency training in PM&R at the University of Pittsburgh Medical Center where she also served as chief resident. Dr. Schmidt's clinical responsibilities include outpatient practice focusing on transition into adulthood for pediatric patients with disabilities, cerebral palsy, amyotrophic lateral sclerosis and other neuromuscular conditions. Dr. Schmidt is rated as a Distinguished provider by MediFind in the treatment of Friedreich Ataxia. She is also highly rated in 49 other conditions, according to our data. Her clinical expertise encompasses Dysferlinopathy, Spinal Muscular Atrophy (SMA), Spinal Muscular Atrophy Type 3, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

Vikram Shakkottai is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Shakkottai is rated as a Distinguished provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, Spinocerebellar Ataxia Type 1, and Drug Induced Dyskinesia.

Erin Knierbein is a Neuromusculoskeletal Medicine specialist and a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Knierbein is rated as an Advanced provider by MediFind in the treatment of Friedreich Ataxia. She is also highly rated in 125 other conditions, according to our data. Her clinical expertise encompasses Danon Disease, Pompe Disease, Dysferlinopathy, and Duchenne Muscular Dystrophy. Dr. Knierbein is board certified in Neurology W/Spec Qual Child Neuro and Neuromuscular Medicine.

Alecia K Daunter MD is an Associate Professor of Physical Medicine and Rehabilitation. She completed her medical degree, residency, and fellowship training at the University of Michigan. She is board certified in Physical Medicine and Rehabilitation. She joined the Michigan Medicine faculty in 2018.Dr. Daunter's research interests include function and quality of life outcomes in patients with developmental disabilities or pediatric onset medical conditions. Dr. Daunter is rated as an Advanced provider by MediFind in the treatment of Friedreich Ataxia. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Spastic Diplegia Infantile Type, Spasticity, Spinal Muscular Atrophy with Arthrogryposis, and Rhizotomy. Dr. Daunter is board certified in Pediatric Rehabilitation Medicine and Physical Medicine & Rehab.

John K. Fink, MD, is a professor in the Department of Neurology and director of the Neurogenetic Disorders Program in the University of Michigan Medical School. He directs basic science laboratory research focused on identifying genes and mechanisms responsible for age-dependent neurologic degeneration; and on developing treatments for these conditions.Fink's laboratory investigates the molecular basis of inherited neurologic and psychiatric disorders. His clinical expertise focuses on inherited and degenerative disorders of the nervous system. Dr. Fink evaluates individuals of all ages, from infancy through senescence with these disorders, which include lysosomal storage disorders (such as Gaucher disease, Niemann-Pick disease and Fabry disease), ataxias (including Friedreich's ataxia), leukodystrophies (such as Krabbe, CADASIL and adrenoleukodystrophy), familial dystonia, primary lateral sclerosis, Wilson's disease, familial motor neuron disease (including familial amyotrophic lateral sclerosis), familial dementia, and a group of inherited spinal cord disorders known collectively as the Hereditary Spastic Paraplegias (HSPs).Dr. Fink came to the University of Michigan in 1990 as an assistant professor of neurology and director of the Neurogenetic Disorders Clinic. The program provides care and evaluation for individuals and families with inherited and degenerative neurologic disorders; and clinical and molecular laboratory training for physicians and scientists studying these disorders. He was promoted to associate professor in 1996 and professor in 2005.Board-certified in neurology and medical genetics, Dr. Fink received his medical degree in 1980 from the Medical College of Ohio in Toledo. Following internship at the Mayo Clinic in Rochester, Minnesota, he completed a neurology residency in 1984 at the University of Virginia in Charlottesville. Subsequently, he trained in developmental and metabolic neurology and medical genetics at the National Institutes of Health.Dr. Fink has served as the Medical Advisor to the Spastic Paraplegia Foundation since its establishment (2002), and serves as ad hoc reviewer for numerous journals and NIH study sections.A member of the American Society of Human Genetics, American Academy of Neurology, American Neurological Association and the American College of Genetics, Dr. Fink received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association in 2002. In addition, he has been elected by peers to Best Doctors in America annually since 2001. Dr. Fink is rated as an Advanced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Spastic Paraplegia Type 7, Spastic Paraplegia Type 2, Primary Lateral Sclerosis, and CACH Syndrome. Dr. Fink is board certified in Clinical Genetics and Neurology.

Dr. Hornyak is Medical Director of Outpatient Pediatric Rehabilitation Services. He serves on the Evidence Based Practice Committee, and chairs the Evidence Committee, for the AAPM&R. He is actively involved in medical education, serving on the steering committee of the UM Academy of Medical Educators. His teaching has been recognized with departmental (Silver Crutch x 4), medical school (inaugural League of Educational Excellence) and university (Provost’s Teaching Innovation Prize) awards. Dr. Hornyak taught the medical portion of the Team-Based Clinical Decision Making course, the first course offered at UM for Inter-professional Education. He frequently serves on graduate student committees in the UM School of Kinesiology as well. Clinically, Dr. Hornyak practices pediatric and adult PMR. Since joining UM, he has been key in the development of multi-disciplinary care clinics for children and adults with neuromuscular diseases. Dr. Hornyak is rated as an Advanced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Charcot-Marie-Tooth Disease, Hereditary Sensory Neuropathy Type 1 (HSN1), Cerebral Palsy, and Spasticity. Dr. Hornyak is board certified in Physical Medicine & Rehab.

Peter K. Todd, M.D., Ph.D., is an assistant professor in the Department of Neurology in the University of Michigan Medical School.Dr. Todd earned his Bachelor of Science degree in 1994 from the University of California, San Diego. He then entered the Medical Science Training Program at the University of Wisconsin at Madison, where he completed his doctorate in 2002 and medical degree in 2004. His Ph.D research focused on synaptic defects in Fragile X Syndrome, a common inherited cause of cognitive impairment in children.He completed his internship and residency at the Hospital of the University of Pennsylvania in Philadelphia. While there, he did research on the role of the ubiquitin proteasome system and autophagy in Spinal and Bulbar Muscular Atrophy, a polyglutamine disorder, and Fragile X Tremor Ataxia Syndrome (FXTAS). He came to the U-M in 2008 for a clinical and research fellowship in movement disorders and neurogenetics.Todd joined the U-M faculty in 2010 as an assistant professor in movement disorders and neurogenetics, working in the laboratory of Henry L. Paulson, M.D., Ph.D., in the Center for Neurodegenerative Research.His current research is focused on the mechanisms underlying RNA-mediated neurodegeneration in FXTAS and myotonic dystrophy, and how these mechanisms may overlap and inform our understanding of other neurodegenerative disorders. He also sees patients with movement disorders and inherited neurological disease.Dr. Todd has received several academic awards, including a Howard Hughes Undergraduate Research Fellowship, the Francis M. Forester Prize for promise as an academic neurologist, the Samuel Ziritzky Prize for most outstanding research by a neurology resident at Penn and prizes for excellence in research at the International Conference on Unstable Microsatellites in Human Disease, and the U-M neuroscience day. Most recently, Dr Todd received the S. Weir Mitchell Alliance award from the American Academy of Neurology which each year recognizes one early investigator physician scientist who has made important contributions to basic science in neurological disorders.A member of the American Medical Association and the American Academy of Neurology, he has served as an ad-hoc reviewer for the Journal of Biological Chemistry, Neurology, Proceedings of the National Academy of Sciences, Neuron, Science and Human Molecular Genetics.His bibliography includes several peer-reviewed papers, editorials, book reviews and chapters, abstracts and online. Dr. Todd is rated as an Advanced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Fragile X Syndrome, Fragile XE Syndrome, Hereditary Ataxia, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). Dr. Todd is board certified in Neurology.

Sharan Srinivasan is a Neurologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Srinivasan is rated as an Advanced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 108 other conditions, according to our data. His clinical expertise encompasses Hereditary Ataxia, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 4, and Spinocerebellar Ataxia Type 5. Dr. Srinivasan is board certified in Neurology.

Gary Gallagher, MD completed his undergraduate bachelor of science degree in Industrial and Operations Engineering at the University of Michigan. An interest in health sciences, lead him to attend medical school at Wayne State University of Medicine in Detroit, MI where he received his doctorate of medicine in 2008. He completed residency in neurology and fellowship in neuromuscular medicine at the University of Michigan. During final year of residency, he served as chief resident. Following completion of fellowship, Dr. Gallagher joined the neurology faculty at the University of Michigan.Dr. Gallagher is interested in the clinical care of neuromuscular disease, tele-medicine, electrodiagnostic procedures (EMG and intraoperative monitoring). His clinical time is spent in the outpatient neuromuscular clinic providing longitudinal care for patients and on the inpatient service caring for acute neurologic problems including stroke management, epilepsy, neuromuscular crisis and auto-immune neurologic disease. In addition, he has strong interest in medical trainee education and he serves as the neuromuscular fellowship director at the University of Michigan. Finally, Dr. Gallagher has strong interest in patient safety and quality improvement and oversees departmental efforts to improve. Dr. Gallagher is rated as an Advanced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 71 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Multifocal Motor Neuropathy, Inclusion Body Myositis, and Peripheral Neuropathy.

Dr. Rodriguez is Medical Director of the Wheelchair Seating Clinic and PM&R Administrator in the Michigan Bowel Control Clinic and the Wound Care Clinic. She has been actively involved in research with the Spinal Cord Injury Model System. She has written and collaborated on several research publications and written chapters on SCI sequelae in premier journals and textbooks in PM&R. Dr. Rodriguez has been recognized for her teaching of trainees with the Silver Crutch award. She is the associate SCI fellowship program director. She also serves on the International Standards and Autonomic Standards Committees, two crucial committees of the American Spinal Injury Association that are responsible for development of any new standards documents related to SCI, continuous review and improvement of the existing ASIA documents on neurological and autonomic standards and development and oversight of the International Data Sets project. Dr. Rodriguez is rated as an Advanced provider by MediFind in the treatment of Friedreich Ataxia. She is also highly rated in 43 other conditions, according to our data. Her clinical expertise encompasses Neurogenic Bowel, Paraplegia, Spasticity, and Autonomic Dysreflexia.

Wayne Cornblath is a Neurologist and an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Cornblath is rated as an Experienced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Optic Neuritis, Myasthenia Gravis, Increased Intracranial Pressure, and Benign Essential Blepharospasm.

Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is rated as an Experienced provider by MediFind in the treatment of Friedreich Ataxia. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Autonomic Neuropathy. Dr. Feldman is board certified in Neurology and Electrodiagnostic Medicine.

Dr. Krater focuses his clinical care on caring for and improving quality of life of individuals with functional limitations. His philosophy for medical care is to guide patients to develop the skills and supports to access their communities, to build a life within their communities, and to live as independently as possible. Dr. Krater is rated as an Experienced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cerebral Palsy, Spastic Diplegia Infantile Type, Spasticity, Dysferlinopathy, and Rhizotomy.

Dr. Bowman completed her residency in Physical Medicine and Rehabilitation at Wayne State University/Detroit Medical Center in 2017. She then completed a Pediatric Rehabilitation Medicine fellowship at the University of Michigan in 2019. Dr. Bowman sees pediatric patients with a variety of conditions, including TBI, SCI, Cerebral Palsy, Neuromuscular diseases, and other conditions affecting development. Dr. Bowman is rated as an Experienced provider by MediFind in the treatment of Friedreich Ataxia. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Myotonia Congenita, Spasticity, and Spastic Diplegia Infantile Type.

Dr. Jessica Pruente attended medical school at Michigan State University, College of Human Medicine, and completed her residency training in PM&R at the University of Colorado in 2016. She also completed a Pediatric Rehabilitation Medicine fellowship at the Shirley Ryan AbilityLab (formerly Rehabilitation Institute of Chicago) in 2018. Dr. Pruente’s clinical responsibilities include outpatient rehabilitation management of children with Cerebral Palsy, Spina Bifida, and other neurologic or musculoskeletal conditions affecting development. Her research interests include the early identification of Cerebral Palsy and early intervention to improve outcomes. Dr. Pruente is rated as an Experienced provider by MediFind in the treatment of Friedreich Ataxia. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Myelomeningocele, Cerebral Palsy, Tethered Cord Syndrome, and Moebius Syndrome.

Dr. Suh received his M.D. and Ph.D. from the University of Cincinnati College of Medicine, and his Master of Health Science degree from Duke University. He completed his internal medicine residency at Cleveland Clinic and fellowship training in geriatric medicine at Duke University and Durham VA Medical Center. Dr. Suh has been board-certified in internal medicine and geriatric medicine. His clinical and research interests include geriatric and functional assessment, geriatric consultation, dementia care, fall prevention, osteoporosis, oral health, sleep disorders, medication use in older adults, and telehealth.Dr. Suh is a faculty member at both the University of Michigan and the Ann Arbor VA Hospital, and he serves as Medical Director of Turner Geriatric Clinic at East Ann Arbor for Michigan Medicine. Dr. Suh is a Fellow of the American Geriatrics Society (AGS) and serves as the Co-Chair for the Oral Health and Aging Special Interest Group for AGS. Ypsilanti, MI. Dr. Suh is rated as an Experienced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Sciatica. Dr. Suh is board certified in Geriatric Medicine.

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is rated as an Experienced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology.

Sami Barmada, M.D., Ph.D. is an assistant professor of neurology at the University of Michigan Medical School. His clinical interests center around patients with dementia and motor neuron disease, and he sees patients at the Cognitive Disorders Clinic in the University of Michigan’s East Ann Arbor location.His research focuses on the pathologic overlap between amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), and how we can take advantage of the convergence to identify new and effective therapies for these devastating disorders.After graduating from the University of Pittsburgh, Pennsylvania, in 1998 with a major in Molecular Biology, Biochemistry, and a focus in Conceptual Foundations of Medicine, Dr. Barmada went on to the Medical Scientist Training Program at Washington University in St. Louis School of Medicine. For his graduate work, he constructed a transgenic mouse model of Creutzfeldt-Jacob disease with Dr. David Harris, and used these animals to track the deposition of misfolded prion protein within the nervous system of infected animals. For this work, Dr. Barmada earned earned the Poletsky Award from the Alzheimer’s Disease Research Center in St. Louis, Missouri, and was elected as a Olin Medical Scientist Fellow at Washington University School of Medicine.Dr. Barmada received his M.D. and Ph.D. in 2006, and completed an Internal Medicine internship at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, before moving to the University of California, San Francisco (UCSF), Medical Center for his residency in Neurology. Dr. Barmada served one year as Chief Resident in the Department of Neurology, focusing on resident education. He was also a house-staff nominee to the Alpha-Omega-Alpha honor society. During his residency, Dr. Barmada became involved in research with Dr. Steve Finkbeiner of the Gladstone Institutes, a pioneer in neuronal models of neurodegenerative disease and novel technologies to study these models. Dr. Barmada finished his residency in 2010 and spent one year working with Dr. Finkbeiner as a research fellow, before becoming a Staff Scientist at the Gladstone Institutes and a Clinical Instructor at UCSF. In 2013, Dr. Barmada became an Assistant Professor of Neurology at the University of Michigan, where he divides his time between the Cognitive Disorders Clinic and the laboratory. Dr. Barmada is rated as an Experienced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Frontotemporal Dementia, and Dementia. Dr. Barmada is board certified in Neurology.

Maryam Berri MD, is a Clinical Assistant Professor in the Department of Physical Medicine and Rehabilitation at the University of Michigan Medical School.Clinical work includes concomitant traumatic brain and spinal cord injury, myelomeningocele, cerebral palsy, and neurogenic bowel disease treatment. She is pursuing research in lactational outcomes and management for those with neurological disease. She has a strong interest in medical education as well as education and optimization in practice management for faculty. She serves as the revenue physician lead for the department. She is an active in the rehabilitation Standards Committee with the American Spinal Injury Association.Dr. Berri received her BS degree from the University of Michigan in 2009, and then in 2013, she graduated from the American University of the Caribbean in Pembroke Pines, FL. She then completed her residency in Physical Medicine and Rehabilitation at Wayne State University followed by subspecialty fellowship in Spinal Cord Injury at the University of Michigan. Dr. Berri is rated as an Experienced provider by MediFind in the treatment of Friedreich Ataxia. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Autonomic Dysreflexia, Brown-Sequard Syndrome, Spasticity, and Neurogenic Bowel. Dr. Berri is board certified in Physical Medicine & Rehab, Spinal Cord Injury Medicine, and Brain Injury Medicine.

Dr. Jonathan P. Etter is an Assistant Professor in the Department of Physical Medicine and Rehabilitation (PM&R) at Michigan Medicine. After the conclusion of his undergraduate studies, he attained a PhD in Pharmaceutical Sciences (Medicinal Chemistry) prior to attending medical school. He then completed his residency in PM&R, followed by fellowships in both Sports Medicine and Spinal Cord Injury (SCI) Medicine. From a Sports Medicine perspective, Dr. Etter specializes in the non-surgical management of musculoskeletal conditions, including those related to sports injuries, as well as bone, joint, tendon, ligament, and peripheral nerve injuries and conditions. He also specializes in the management of SCI-related issues, including spasticity, neurogenic bowel, neurogenic bladder, neuropathic pain, and physical functioning. He has particular interests in strength, combat, endurance and adaptive sports athletes, ultrasound-guided injections and interventions, sports nutrition and performance, preventative medicine, and regenerative medicine. Dr. Etter is rated as an Experienced provider by MediFind in the treatment of Friedreich Ataxia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Neurogenic Bowel, Spasticity, Paraplegia, and Foot Drop.